Duncker Streett & CO Inc Novartis Ag Transaction History
Duncker Streett & CO Inc
- $542 Million
- Q2 2025
A detailed history of Duncker Streett & CO Inc transactions in Novartis Ag stock. As of the latest transaction made, Duncker Streett & CO Inc holds 552 shares of NVS stock, worth $64,379. This represents 0.01% of its overall portfolio holdings.
Number of Shares
552
Previous 552
-0.0%
Holding current value
$64,379
Previous $61,000
8.2%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding NVS
# of Institutions
1,544Shares Held
141MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.38 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.21 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$1 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$823 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$789 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $251B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...